Select your language

Leibniz Research Alliance
INFECTIONS in an Urbanizing World - Humans, Animals, Environments

Improved hygiene and better prevention and treatment have diminished the incidence of infectious diseases particularly in industrialised countries. However, increasing antibiotic resistance, emergence of new pathogens, together with changes in pathogen distribution due to altered climate and mobility are global challenges for humankind. The Leibniz Research Alliance (LRA) INFECTIONS aims to establish an interdisciplinary research agenda and opens up new avenues of communication across disciplines. New strategies and methods for early warning and outbreak management systems will be developed to control spread of pathogens.

NEWS

  • Stenotrophomonas maltophilia: The Silent Rise of a Superbug

    The multidrug-resistant opportunist Stenotrophomonas maltophilia plays a central role in one of our projects: it is part of mixed biofilms in which the interactions between pulmonary opportunists and emerging antimicrobial resistance are studied (IPT2, further description HERE). At the highly respected American Society for Microbiology (ASM) conference "ASM Microbe 2022" held in June, there was intense discussion about this pathogen, which is increasingly developing resistance to conventional drugs.  The video recorded live in Washington DC is available HERE .

  • New molecules inhibiting the formation of biofilm by different opportunistic pathogens

    Press Release of the Autonomous University of Barcelona (UAB), 05.09.2022

    Researchers from the Bacterial Pathogenesis and Antimicrobials group of the Institut de Biotecnologia i de Biomedicina (IBB) and the Department of Genetics and Microbiology at UAB, have evaluated several compounds that have been shown to inhibit biofilm formation in important opportunistic human pathogens. The targets of these molecules include multidrug-resistant Gram-negative and Gram-positive pathogenic bacteria as well as the fungal pathogen Candida albicans. The study was carried out in a collaboration which involved three more European laboratories.

  • Welcome to the team! New associated project in the Leibniz Research Alliance

    Since May, 31 we can be pleased about a new associated project in our alliance:

    Vitality

    More than 2 million children globally live with HIV, 90% of them in sub-Saharan Africa. Vitality is an EDCTP (European & Developing Countries Clinical Trials Partnership) funded clinical study in Zambia and Zimbabwe analysing the effect of vitamin D supplementation on health improvement of HIV-positive children.

     

 

Team Zeichenfläche 1

Partner


 
blog Zeichenfläche 1

Blog


 
projects Zeichenfläche 1

Current projects


 
termine Zeichenfläche 1

News & Dates

 
Speaker
Prof. Dr. Ulrich E. Schaible
Research Center Borstel, Leibniz Lung Center (FZB)
T +49 4537 188 6000
uschaible@fz-borstel.de
 
Coordination
Dr. Susanne Pätzold
Research Center Borstel, Leibniz Lung Center (FZB)
T 04537 188 5840
spaetzold@fz-borstel.de
 
Public Relation
Britta Weller
Research Center Borstel, Leibniz Lung Center (FZB)
T 04537 188 2870
bweller@fz-borstel.de
 

Dr. Anna Holst
Research Center Borstel, Leibniz Lung Center (FZB)
T 04537 188 2690
aholst@fz-borstel.de